Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; ''ecstasy'')

被引：28
|
作者：
Cohen, RS
机构：
[1] Research Department, Peapack, NJ
[2] Research Department, Peapack, NJ 07977
来源：
BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 09期
关键词：
ecstasy; MDMA; drug use; serotonin; suicide;
D O I：
10.1016/0006-3223(95)00551-X
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：819 / 820
页数：2
相关论文
共 50 条
  • [21] 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth
    Lake, Stephanie
    Gaddis, Andrew
    Tupper, Kenneth W.
    Nosova, Ekaterina
    DeBeck, Kora
    SUBSTANCE ABUSE, 2019, 40 (03) : 350 - 355
  • [22] Memory deficits associated with recreational use of “ecstasy” (MDMA)
    Michael John Morgan
    Psychopharmacology, 1999, 141 : 30 - 36
  • [23] Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use
    Gouzoulis-Mayfrank, E
    Fischermann, T
    Rezk, M
    Thimm, B
    Hensen, G
    Daumann, J
    DRUG AND ALCOHOL DEPENDENCE, 2005, 78 (03) : 317 - 323
  • [24] Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, ecstasy') and related psychostimulants: mechanisms and mediators
    Vanattou-Saifoudine, N.
    McNamara, R.
    Harkin, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (05) : 946 - 959
  • [25] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
  • [26] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [27] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    Psychopharmacology, 2011, 217 : 475 - 484
  • [28] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335
  • [29] Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
    Liechti, ME
    Baumann, C
    Gamma, A
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) : 513 - 521
  • [30] Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
    Matthias E Liechti
    Christine Baumann
    Alex Gamma
    Franz X Vollenweider
    Neuropsychopharmacology, 2000, 22 : 513 - 521
12345